Intralesional pentoxifylline, triamcinolone acetonide, and their combination for treatment of keloid scars
- 17 June 2021
- journal article
- research article
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 20 (10) , 3330-3340
Abstract
Background: Keloids are common fibroproliferative tumors, and their treatment still represents a dilemma. Intralesional triamcinolone acetonide (TAC) injection is effective, but frequently associated with side effects. Pentoxifyllin (PTX) is a vasodilator, anti‐inflammatory, and antifibrotic agent. Its intralesional injection in keloids has not been evaluated yet.Aims: Evaluating the efficacy and safety of intralesional PTX versus intralesional TAC and their combination for treatment of keloids.Patients/Methods: Thirty patients with keloids were divided into three equal groups and treated by intralesional injection of TAC, PTX, or their combination (admixed in 1:1 ratio). Injections were repeated every 3 weeks until lesional flattening or for maximum of 5 sessions. The evaluation was done using the Vancouver Scar Scale and the Verbal Rating Scale for pain and itching.Results: A significant improvement in VSS was detected in all groups. Significantly better improvements in keloid height, pliability, pain, and itching were detected in the TAC and combination groups than in the PTX group. There was a significantly higher incidence of side effects (atrophy, hypopigmentation, telangiectasia, and precipitation of TAC) in the TAC group than in the combination group, while no side effects were reported in the PTX group. A statistically significant reduction in the number of treatment sessions (required to achieve best results) was detected in patients in the combination group.Conclusions: Intralesional injection of PTX is a potentially helpful, safe, and well‐tolerated therapeutic tool for keloids, but with lower efficacy than intralesional TAC when used solely. Combining PTX and TAC produces significantly better results for keloid treatment and lowers the risk of TAC‐induced side effects.Keywords
This publication has 31 references indexed in Scilit:
- Pentoxifylline treatment and penile calcifications in men with Peyronie's diseaseAsian Journal of Andrology, 2010
- Intralesional pentoxifylline as an adjuvant treatment for perioral post-burn hypertrophic scarsBurns, 2010
- Comparison of the Particle Sizes of Different Steroids and the Effect of DilutionAnesthesiology, 2007
- The reinnervation pattern of wounds and scars may explain their sensory symptomsJournal of Plastic, Reconstructive & Aesthetic Surgery, 2006
- Dexamethasone Induction of Keloid Regression through Effective Suppression of VEGF Expression and Keloid Fibroblast ProliferationJournal of Investigative Dermatology, 2006
- Pentoxifylline inhibits mature burn scar fibroblasts in cultureBurns, 2006
- Effects of pentoxifylline on sputum neutrophil elastase and pulmonary function in patients with cystic fibrosis: Preliminary observationsThe Journal of Pediatrics, 1994
- Pentoxifylline inhibits the proliferation of human fibroblasts derived from keloid, scleroderma and morphoea skin and their production of collagen, glycosaminoglycans and fibronectinBritish Journal of Dermatology, 1990
- Rating the Burn ScarJournal of Burn Care & Rehabilitation, 1990
- PentoxifyllineDrugs, 1987